Xeris Biopharma Holdings Inc (NASDAQ:XERS)
| 1.22 Delayed Data As of Feb 01 |  -0.02 / -1.61%Today’s Change | 0.97 Today|||52-Week Range 2.95 | -8.27% Year-to-Date |
Latest XERS News | Press Releases
No recent news for Xeris Biopharma Holdings Inc.
Today’s Trading
| Previous close | 1.24 |
| Today’s open | 1.23 |
| Day’s range | 1.19 - 1.26 |
| Volume | 717,840 |
| Average volume (3 months) | 915,183 |
| Market cap | $174.1M |
Data as of 3:59pm ET, 02/01/2023
Growth & Valuation
| Earnings growth (last year) | +27.34% |
| Earnings growth (this year) | +56.49% |
| Earnings growth (next 5 years) | +28.00% |
| Revenue growth (last year) | +142.67% |
| P/E ratio | NM |
| Price/Sales | 4.67 |
| Price/Book | 1.68 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Ecogreen Internation... | 0.00 | 0.00% |
| OVIDOvid Therapeutics In... | -0.08 | -3.20% |
| DMTRF3-D Matrix Ltd | 0.00 | 0.00% |
| EYPTEyePoint Pharmaceuti... | +0.09 | +1.93% |
Data as of 3:59pm ET, 02/01/2023
Financials
| Next reporting date | March 8, 2023 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $49.6M |
| Annual profit (last year) | -$122.7M |
| Net profit margin | -247.48% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Chicago, Illinois |
Forecasts
